Form 4 for BVS Bioventus Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-15 · accession 0001914936-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-15 | BVS | Singleton Mark Leonard | SVP, CFO | M - OptEx | $0.00 | +20.2K | 161.2K | +14% | $0 |
| D | 2026-02-18 | 2026-02-15 | BVS | Singleton Mark Leonard | SVP, CFO | F - Tax | $8.27 | -9,429 | 151.8K | -6% | -$78.0K |
| D | 2026-02-18 | 2026-02-15 | BVS | Singleton Mark Leonard | SVP, CFO | M - OptEx | $0.00 | -20.2K | 40.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-15 | M | A | 20,153 | $0.00 | 161,241 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-02-15 | F | D | 9,429 | $8.27 | 151,812 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-02-15 | M | D | 20,153 | $0.00 | 40,304 | D | — · — to — | 20,153 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date. |